 |
|
Psoriasis and the Risk of Diabetes and HypertensionA Prospective Study of US Female Nurses
Abrar A. Qureshi, MD, MPH;
Hyon K. Choi, MD, DrPH;
Arathi R. Setty, MD, MPH;
Gary C. Curhan, MD, ScD
Arch Dermatol. 2009;145(4):379-382.
Objective To evaluate the independent association between psoriasis and risk of diabetes and hypertension.
Design A prospective study of female nurses who were followed up from 1991 to 2005.
Setting Nurses' Health Study II, a cohort of 116 671 US women aged 27 to 44 years in 1991.
Participants The study included 78 061 women who responded to a question about a lifetime history of physician-diagnosed psoriasis in 2005. Women who reported a diagnosis of diabetes or hypertension at baseline were excluded.
Main Outcome Measure New diagnosis of diabetes or hypertension, obtained from biennial questionnaires.
Results Of the 78 061 women, 1813 (2.3%) reported a diagnosis of psoriasis. During the 14 years of follow-up, a total of 1560 incident cases (2%) of diabetes and 15 724 incident cases (20%) of hypertension were documented. The multivariate-adjusted relative risk of diabetes in women with psoriasis compared with women without psoriasis was 1.63 (95% confidence interval, 1.25-2.12). Women with psoriasis were also at an increased risk for the development of hypertension (multivariate relative risk, 1.17; 95% confidence interval, 1.06-1.30). Age, body mass index, and smoking status did not significantly modify the association between psoriasis and risk of diabetes or hypertension (P values for interaction,  .07).
Conclusions In this prospective analysis, psoriasis was independently associated with an increased risk of diabetes and hypertension. Future studies are needed to find out whether psoriasis treatment will reduce the risk of diabetes and hypertension.
Author Affiliations: Channing Laboratory, Department of Medicine (Drs Qureshi, Choi, Setty, and Curhan), and Department of Dermatology (Dr Qureshi), Brigham and Women's Hospital and Harvard Medical School, and Department of Epidemiology, Harvard School of Public Health (Dr Curhan), Boston, Massachusetts.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Dermatologic Comorbidities of Diabetes Mellitus and Related Issues
William H. Eaglstein and Jeffrey P. Callen
Arch Dermatol. 2009;145(4):467-469.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Smoking and Risk of Incident Psoriasis Among Women and Men in the United States: A Combined Analysis
Li et al.
Am J Epidemiol 2012;0:kwr325v1-kwr325.
ABSTRACT
| FULL TEXT
Systemic and Vascular Inflammation in Patients With Moderate to Severe Psoriasis as Measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG-PET/CT): A Pilot Study
Mehta et al.
Arch Dermatol 2011;147:1031-1039.
ABSTRACT
| FULL TEXT
Association Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis
Solomon et al.
JAMA 2011;305:2525-2531.
ABSTRACT
| FULL TEXT
Prevalence of the Metabolic Syndrome in Psoriasis: Results From the National Health and Nutrition Examination Survey, 2003-2006
Love et al.
Arch Dermatol 2011;147:419-424.
ABSTRACT
| FULL TEXT
Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
Solomon et al.
Ann Rheum Dis 2010;69:2114-2117.
ABSTRACT
| FULL TEXT
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database
Mehta et al.
Eur Heart J 2009;0:ehp567v1-ehp567.
ABSTRACT
| FULL TEXT
Diabetes and Hypertension: Diseases Associated with Psoriasis
Journal Watch Dermatology 2009;2009:2-2.
FULL TEXT
Dermatologic Comorbidities of Diabetes Mellitus and Related Issues
Eaglstein and Callen
Arch Dermatol 2009;145:467-469.
FULL TEXT
|
